Empagliflozin restores cardiac metabolic flexibility in diet-induced obese C57BL6/J mice-Reference-Cited by-同舟云学术

Empagliflozin restores cardiac metabolic flexibility in diet-induced obese C57BL6/J mice

Published:2022 Issue: Volume:5 Page:232-239
ISSN:2665-9441
Container-title:Current Research in Physiology
language:en
Short-container-title:Current Research in Physiology

Author:

Xie Bingxian,Ramirez Wesley,Mills Amanda M.,Huckestein Brydie R.,Anderson Moira,Pangburn Martha M.,Lang Eric Y.,Mullet Steven J.,Chuan Byron W.,Guo Lanping,Sipula Ian,O'Donnell Christopher P.,Wendell Stacy G.,Scott Iain,Jurczak Michael J.^ORCID

Publisher

Elsevier BV

Subject

Physiology (medical),Physiology

Reference52 articles.

1. Regulation of hepatic fat and glucose oxidation in rats with lipid-induced hepatic insulin resistance;Alves;Hepatology,2011

2. Empagliflozin limits myocardial infarction in vivo and cell death in vitro: role of STAT3, mitochondria, and redox aspects;Andreadou;Front. Physiol.,2017

3. Empagliflozin in heart failure with a preserved ejection fraction;Anker;N. Engl. J. Med.,2021

4. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial;Bailey;Lancet,2010

5. A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial;Brown;Eur. Heart J.,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Megalin Knockout Reduces SGLT2 Expression and Sensitizes to Western Diet-induced Kidney Injury;Function;2024

2. Effect of Alpha-Linolenic Acid Supplementation on Cardiovascular Disease Risk Profile in Individuals with Obesity or Overweight: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Advances in Nutrition;2023-11

3. The neurometabolic axis: A novel therapeutic target in heart failure;Life Sciences;2023-11

4. A Prospective Cohort Protocol for the Remnant Investigation in Sepsis Study;Critical Care Explorations;2023-10-27

5. Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytes;Journal of Translational Medicine;2023-09-23